Protecting Innovation

Biotechnology innovations is helping Maryland patients access the cures and advancements in treatment they need every day.

  • Modern biotechnology provides breakthrough products and technologies to combat debilitating and rare diseases.
  • There are currently more than 250 biotechnology health care products and vaccines available to Maryland patients, many for previously untreatable diseases.

The biotechnology industry is a critical jobs creator in Maryland.

  • The biotechnology industry employs more than 41,000 Marylanders in good, high paying jobs and invests billions in the state annually.
  • Maryland is ranked #3 in the country in innovation and entrepreneurship, according to the U.S. Chamber of Commerce. Few states rival Maryland’s combination of a superior workforce, technological prowess, market access, and tech-centered policy incentives.

Protecting the innovation economy requires action. Lawmakers in Annapolis should take steps to protect patient access to care and Maryland’s strong innovative spirit.

  • Over 1,000 Marylanders have already signed a petition urging Annapolis to focus only on legislation that protects patients and grows Maryland’s innovative business environment.

The Maryland Tech Council supports health policies that are patient-centered, holistic, and promote patient access to cures.

  • The Maryland Tech Council advocates for policies that will bring new treatments to Maryland patients with serious medical conditions, promote innovation, and improve patient access.

Misguided drug pricing transparency legislation will harm patient access to care, stifle investment in Maryland, and do nothing to address the price consumers pay for medicine.

  • In 2017, Maryland passed drug price transparency legislation. Additional, heavyhanded drug pricing legislation risks undermining competition, disrupting product availability and stifling investment in the Maryland innovation economy.


Maryland Tech Council CEO Marty Rosendale Responds to Governor Hogan’s State of the State
January 30, 2019

January 30th, 2019. (Annapolis) In response go Governor Larry Hogan’s 2019 State of the State Address, Maryland Tech Council CEO Marty Rosendale released the following statement about innovation and the benefits it provides to Maryland’s economy and the patients who rely on it. The Maryland Tech Council is a collection of over 450 life science and technology companies across Maryland and advocates for commonsense regulation supporting innovation.

“The Maryland Tech Council commends Governor Hogan for his ongoing work to boost innovation and cultivate a positive business climate in Maryland, including his proposal for over a half-billion dollars in additional, much-needed tax relief. These efforts help foster private sector job growth, bring new business to Maryland, and help Maryland small businesses compete domestically and internationally. We also support his efforts to help patients in his first term, and his focus on improving health care moving forward.

“We agree with Governor Hogan that Maryland is a national leader in health care, and that it is critical to continue to foster the innovation that makes this possible. We also support the governor’s calls from earlier this month to avoid attempted solutions that are unconstitutional or illegal, as legislation aimed at price-gouging in 2017 was ruled.

“Any attempt to address rising costs must also be sure to continue to foster innovation that helps companies in Maryland produce the life-saving cures that patients in our state and around the world rely on. Onerous regulations, as have been proposed in years past, would undercut this innovation and the breakthrough cures that rely on the innovation economy.

“In 2019, the Maryland Tech Council looks forward to working with Governor Hogan and the Maryland General Assembly to foster innovation in Maryland that helps set us apart as a health care leader."